As of 2025-12-05, the Relative Valuation of Verrica Pharmaceuticals Inc (VRCA) is (206.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.55 USD, the upside of Verrica Pharmaceuticals Inc based on Relative Valuation is -2837.0%.
The range of the Relative Valuation is (210.49) - (217.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 19.2x | 17.4x |
| Forward P/E multiples | 18.6x - 20.9x | 19.2x |
| Fair Price | (210.49) - (217.26) | (206.65) |
| Upside | -2887.9% - -2977.6% | -2837.0% |
| Date | P/E |
| 2025-11-28 | -0.81 |
| 2025-11-26 | -0.59 |
| 2025-11-25 | -0.45 |
| 2025-11-24 | -0.42 |
| 2025-11-21 | -0.37 |
| 2025-11-20 | -0.36 |
| 2025-11-19 | -0.40 |
| 2025-11-18 | -0.34 |
| 2025-11-17 | -0.33 |
| 2025-11-14 | -0.35 |
| 2025-11-13 | -0.34 |
| 2025-11-12 | -0.34 |
| 2025-11-11 | -0.32 |
| 2025-11-10 | -0.34 |
| 2025-11-07 | -0.31 |
| 2025-11-06 | -0.32 |
| 2025-11-05 | -0.31 |
| 2025-11-04 | -0.29 |
| 2025-11-03 | -0.32 |
| 2025-10-31 | -0.32 |
| 2025-10-30 | -0.31 |
| 2025-10-29 | -0.32 |
| 2025-10-28 | -0.32 |
| 2025-10-27 | -0.33 |
| 2025-10-24 | -0.34 |
| 2025-10-23 | -0.35 |
| 2025-10-22 | -0.35 |
| 2025-10-21 | -0.36 |
| 2025-10-20 | -0.40 |
| 2025-10-17 | -0.37 |
| 2025-10-16 | -0.37 |
| 2025-10-15 | -0.36 |
| 2025-10-14 | -0.36 |
| 2025-10-13 | -0.36 |
| 2025-10-10 | -0.37 |
| 2025-10-09 | -0.38 |
| 2025-10-08 | -0.39 |
| 2025-10-07 | -0.41 |
| 2025-10-06 | -0.42 |
| 2025-10-03 | -0.41 |
| 2025-10-02 | -0.40 |
| 2025-10-01 | -0.39 |
| 2025-09-30 | -0.38 |
| 2025-09-29 | -0.38 |
| 2025-09-26 | -0.37 |
| 2025-09-25 | -0.36 |
| 2025-09-24 | -0.37 |
| 2025-09-23 | -0.38 |
| 2025-09-22 | -0.39 |
| 2025-09-19 | -0.39 |